stem cells

In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Stat
CRISPR
Verve Therapeutics
stem cells
cholesterol
Flag link:
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments
Xconomy
ViaCyte
diabetes
gene editing
stem cells
Flag link:
One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data
One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data
Endpoints
Capricor
stem cells
Duchenne Muscular Dystrophy
CAP-1002
Flag link:
Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Forbes
Mesoblast
Australia
clinical gtrials
ARDS
COVID-19
stem cells
remestemcel-L
Flag link:
Reversing diabetes with CRISPR and patient-derived stem cells
Reversing diabetes with CRISPR and patient-derived stem cells
Fierce Biotech
diabetes
CRISPR
stem cells
Flag link:
Citius, Novellus collaborate on novel stem-cell therapy for ARDS associated with COVID-19
Citius, Novellus collaborate on novel stem-cell therapy for ARDS associated with COVID-19
Pharmaceutical Business Review
Citius Pharmaceuticals
Novelius
stem cells
ARDS
COVID-19
Flag link:
Rudy Giuliani wants FDA to fast-track a stem cell therapy for Covid-19; critics see political meddling
Rudy Giuliani wants FDA to fast-track a stem cell therapy for Covid-19; critics see political meddling
STAT
Rudy Giuliani
politics
FDA
stem cells
COVID-19
Flag link:
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Flag link:
Omeros hits endpoint in pivotal stem cell transplant study
Omeros hits endpoint in pivotal stem cell transplant study
Fierce Biotech
Omeros
narsoplimab
stem cells
stem cell transplant
clinical trials
Flag link:
Stem Cell Therapy Works for Cardiac Patients, But Not in the Way We Think
Stem Cell Therapy Works for Cardiac Patients, But Not in the Way We Think
Xtalks
stem cells
Cardiac
heart attack
Flag link:
ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer
ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer
Fierce Biotech
ExCellThera
umbilical cord blood
cord blood
stem cells
blood cancers
Flag link:
ReNeuron shares clinical data on stem cell vision loss therapy
ReNeuron shares clinical data on stem cell vision loss therapy
Fierce Biotech
ReNeuron
stem cells
Retinitis pigmentosa
vision loss
Flag link:
How Viagra could boost a widely used blood cancer treatment
How Viagra could boost a widely used blood cancer treatment
Fierce Biotech
Viagra
Pfizer
stem cells
bone marrow
blood cancer
Sanofi
Mozobil
Flag link:
Lawmakers press Sharpless to bring stem cell companies into line
Lawmakers press Sharpless to bring stem cell companies into line
BioCentury
FDA
stem cells
Ned Sharpless
Flag link:
Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration
Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration
BioSpace
Takeda
Kyoto University
CAR-T
stem cells
Flag link:
Here's Why Athersys Is Soaring Today
Here's Why Athersys Is Soaring Today
Motley Fool
Athersys
Japan
clinical trials
stem cells
MultiStem
ARDS
Flag link:
Mesoblast poised to file cell therapy for GVHD in US
Mesoblast poised to file cell therapy for GVHD in US
Pharmaforum
Mesoblast
stem cells
graft vs host disease
FDA
remestemcel-L
Flag link:
Off-the-shelf CAR-T from stem cells? An early look at UCLA tech — licensed by Gilead
Off-the-shelf CAR-T from stem cells? An early look at UCLA tech — licensed by Gilead
Endpoints
CAR-T
Gilead Sciences
UCLA
stem cells
Flag link:
Korean biotechs snatch U.S. stem cell manufacturing facility
Korean biotechs snatch U.S. stem cell manufacturing facility
Fierce Pharma
Korea
stem cells
Flag link:
Daiichi Sankyo takes option on diabetes stem cell start-up
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive
Flag link:

Pages